Abstract:Aging induces profound alterations in host biology and correlates with unfavorable clinical outcomes in age-related diseases such as cancer. While the pivotal role of the immune system in regulating tumor progression is well-acknowledged, the precise mechanisms through which aging influences anti-tumor T cell immunity and responsiveness to immune checkpoint blockade (ICB) remain elusive. In this study, we employed syngeneic murine tumor models (B16, MC38, and E0771) in young (2-4 months) and aged (20-24 months) cohorts to elucidate the early impacts of aging on tumor development and T cell responses. Our findings demonstrate that aged mice exhibit accelerated tumor growth across various models. In-depth analysis of tumor-infiltrating lymphocytes (TILs) uncovered distinct alterations in the CD8+ T cell population, characterized by decreased activation status and diminished tumor specificity in aged mice. Correspondingly, aged mice exhibited resistance to anti-PD-1 immunotherapy. To unravel the underlying environmental factors contributing to compromised anti-tumor T cell responses and ICB resistance, we characterized the immune and metabolic landscapes of the aged tumor-draining lymph nodes and tumors. Furthermore, we established a genetically engineered mouse model of lung adenocarcinoma in both young and aged mice, unveiling novel functions and mechanisms associated with age-related T cells actively impeding effective tumor control. In the context of increasing average life expectancy, comprehending the intricate interplay between age-related T cell dysfunction and cancer assumes paramount importance. Such insights hold the key to the development of innovative therapeutic strategies tailored for the growing population of older patients. Citation Format: SeongJun Han, Peter Georgiev, Jaime Schneider, Amy Huang, Zhanel Nugmanova, Thao H. Nguyen, Conghui Yao, Sheila Johnson, Shakchhi Joshi, Ishita Dhiman, Jefte M. Drijvers, Megan Fung, Jared H. Rowe, Brian C. Miller, Gordon J. Freeman, Alison E. Ringel, Marcia C. Haigis, Arlene H. Sharpe. Deciphering the effects of age on T cell immunity and immunotherapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6592.

Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors

"Boosting" tumor immunity in elderly mice by hyperactivating dendritic cells

The aged tumor microenvironment limits T cell control of cancer

Age-associated contraction of tumor-specific T cells impairs antitumor immunity

Critical role of the CD44lowCD62Llow CD8+ T cell subset in restoring antitumor immunity in aged mice

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice

Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice

Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination

Abstract 6592: Deciphering the effects of age on T cell immunity and immunotherapy

Abstract 3921: The aged tumor microenvironment limits CD8+ T cell control of cancer

Regeneration of Dendritic Cells in Aged Mice

Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination

Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice

Vector prime/protein boost vaccine that overcomes defects acquired during aging and cancer.

Age-associated increase in lifespan of naïve CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects

Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4+ T Cells in Aging

Thymus Reconstitution in Young and Aged Mice Is Facilitated by In Vitro-Generated Progenitor T Cells

Harnessing Biomaterials to Amplify Immunity in Aged Mice through T Memory Stem Cells

Single-cell sequencing characterizes intratumoral profile of immune cells in old mice

Nurture over nature for old antitumor T cells

CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging